Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Cancer immunotherapy : immune suppression and tumor growth / / [edited by] George Prendergast, Elizabeth M. Jaffee
| Cancer immunotherapy : immune suppression and tumor growth / / [edited by] George Prendergast, Elizabeth M. Jaffee |
| Pubbl/distr/stampa | Amsterdam ; ; Boston, : Academic Press, c2007 |
| Descrizione fisica | 1 online resource (429 p.) |
| Disciplina | 616.99/4061 |
| Altri autori (Persone) |
PrendergastGeorge C
JaffeeElizabeth M |
| Soggetto topico |
Cancer - Immunotherapy
Antineoplastic agents - Therapeutic use Tumors - Immunological aspects |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1281020451
9786611020453 0080521851 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Front cover; Cancer Immunotherapy: Immune Suppression and Tumor Growth; Copyright page; Table of contents; Contributors; PART I: PRINCIPLES OF CANCER IMMUNOBIOLOGY; CHAPTER 1: Introduction; I. OVERVIEW; II. HISTORICAL BACKGROUND; III. LOOKING AHEAD: MARRYING CHEMOTHERAPY AND IMMUNOTHERAPY; IV. PARTS OF THE BOOK; References; Further Reading; CHAPTER 2: Cancer Immunoediting: From Immune Surveillance to Immune Escape; I. INTRODUCTION; II. CANCER IMMUNE SURVEILLANCE; III. CANCER IMMUNOEDITING; IV. CONCLUDING REMARKS; References
CHAPTER 3: Immunosurveillance: Innate and Adaptive Antitumor ImmunityI. INTRODUCTION; II. INNATE ANTITUMOR RESPONSES; III. INNATE IMMUNE CELLS; IV. ADAPTIVE ANTITUMOR RESPONSES; V. THE INTERPLAY OF INNATE AND ADAPTIVE ANTITUMOR IMMUNITY; VI. CONCLUSION; References; CHAPTER 4: Cytokine Regulation of Immune Tolerance to Tumors; I. INTRODUCTION; II. CYTOKINE REGULATION OF IMMUNE TOLERANCE TO TUMORS; III. SUMMARY AND FUTURE PERSPECTIVES; References; CHAPTER 5: Immunological Sculpting:Natural Killer Cell Receptorsand Ligands; I. INTRODUCTION; II. ACTIVATING HUMAN NK RECEPTORS III. INHIBITORY NK RECEPTORSIV. THE LY49 RECEPTOR FAMILY; V. IMMUNOTHERAPY APPROACHES; VI. CONCLUSION; References; Further Reading; CHAPTER 6: Immune Escape:Immunosuppressive Networks; I. INTRODUCTION; II. IMBALANCE BETWEEN MATURE DCs AND IMMATURE DCs; III. IMBALANCE BETWEEN STIMULATORY AND INHIBITORY B7 FAMILY MOLECULES; IV. IMBALANCE BETWEEN REGULATORY T CELLS AND CONVENTIONAL T CELLS; V. CONCLUDING REMARKS; References; PART II: CANCER THERAPEUTICS; CHAPTER 7: Cytotoxic Chemotherapy inClinical Treatment of Cancer; I. INTRODUCTION; II. DNA-DAMAGING AGENTS; III. ANTIMETABOLITES IV. ANTIMITOTICS V. CHEMOTHERAPY REGIMENS; References; Useful Web Sites; CHAPTER 8: Targeted Therapeutics in Cancer Treatment; I. INTRODUCTION; II. CELL CYCLE; III. THE MAPK FAMILY; IV. CHALLENGES IN THE CLINICAL DEVELOPMENT OF SIGNAL TRANSDUCTION INHIBITORS; References; CHAPTER 9: Concepts in Pharmacology and Toxicology; I. INTRODUCTION; II. CONCEPTS IN PHARMACOKINETICS; III. CONCEPTS IN TOXICOLOGY; IV. CLINICAL CONCERNS FOR PHARMACOLOGY AND SAFETY; V. CONCLUSION; References; Further Reading; CHAPTER 10: Cancer Immunotherapy:Challenges and Opportunities; I. INTRODUCTION II. PREREQUISITES FOR EFFECTIVE CANCER IMMUNOTHERAPY: IDENTIFYING TUMOR ANTIGENS III. ADOPTIVE ("PASSIVE") IMMUNOTHERAPY; IV. ACTIVE-SPECIFIC IMMUNOTHERAPY: VACCINES; V. CANCER-INDUCED IMMUNOSUPPRESSION IMPINGES ON IMMUNOTHERAPY; VI. CANCER IMMUNOTHERAPY IN MICE VERSUS HUMANS; VII. IMMUNOTHERAPY AND CANCER STEM CELLS; VIII. AUTOIMMUNITY RESULTING FROM CANCER IMMUNOTHERAPY; IX. CONCLUSION AND FUTURE CONSIDERATIONS; References; CHAPTER 11: Cancer Vaccines; I. INTRODUCTION; II. TUMOR ANTIGENS; III. SPONTANEOUS IMMUNITY TO CANCER; IV. TOLERAGENIC PRESSURE ON IMMUNITY TO CANCER V. IMMUNE RESPONSES TO CONVENTIONAL VACCINES |
| Record Nr. | UNINA-9910458644103321 |
| Amsterdam ; ; Boston, : Academic Press, c2007 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Cancer immunotherapy : immune suppression and tumor growth / / [edited by] George Prendergast, Elizabeth M. Jaffee
| Cancer immunotherapy : immune suppression and tumor growth / / [edited by] George Prendergast, Elizabeth M. Jaffee |
| Pubbl/distr/stampa | Amsterdam ; ; Boston, : Academic Press, c2007 |
| Descrizione fisica | 1 online resource (429 p.) |
| Disciplina | 616.99/4061 |
| Altri autori (Persone) |
PrendergastGeorge C
JaffeeElizabeth M |
| Soggetto topico |
Cancer - Immunotherapy
Antineoplastic agents - Therapeutic use Tumors - Immunological aspects |
| ISBN |
1281020451
9786611020453 0080521851 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Front cover; Cancer Immunotherapy: Immune Suppression and Tumor Growth; Copyright page; Table of contents; Contributors; PART I: PRINCIPLES OF CANCER IMMUNOBIOLOGY; CHAPTER 1: Introduction; I. OVERVIEW; II. HISTORICAL BACKGROUND; III. LOOKING AHEAD: MARRYING CHEMOTHERAPY AND IMMUNOTHERAPY; IV. PARTS OF THE BOOK; References; Further Reading; CHAPTER 2: Cancer Immunoediting: From Immune Surveillance to Immune Escape; I. INTRODUCTION; II. CANCER IMMUNE SURVEILLANCE; III. CANCER IMMUNOEDITING; IV. CONCLUDING REMARKS; References
CHAPTER 3: Immunosurveillance: Innate and Adaptive Antitumor ImmunityI. INTRODUCTION; II. INNATE ANTITUMOR RESPONSES; III. INNATE IMMUNE CELLS; IV. ADAPTIVE ANTITUMOR RESPONSES; V. THE INTERPLAY OF INNATE AND ADAPTIVE ANTITUMOR IMMUNITY; VI. CONCLUSION; References; CHAPTER 4: Cytokine Regulation of Immune Tolerance to Tumors; I. INTRODUCTION; II. CYTOKINE REGULATION OF IMMUNE TOLERANCE TO TUMORS; III. SUMMARY AND FUTURE PERSPECTIVES; References; CHAPTER 5: Immunological Sculpting:Natural Killer Cell Receptorsand Ligands; I. INTRODUCTION; II. ACTIVATING HUMAN NK RECEPTORS III. INHIBITORY NK RECEPTORSIV. THE LY49 RECEPTOR FAMILY; V. IMMUNOTHERAPY APPROACHES; VI. CONCLUSION; References; Further Reading; CHAPTER 6: Immune Escape:Immunosuppressive Networks; I. INTRODUCTION; II. IMBALANCE BETWEEN MATURE DCs AND IMMATURE DCs; III. IMBALANCE BETWEEN STIMULATORY AND INHIBITORY B7 FAMILY MOLECULES; IV. IMBALANCE BETWEEN REGULATORY T CELLS AND CONVENTIONAL T CELLS; V. CONCLUDING REMARKS; References; PART II: CANCER THERAPEUTICS; CHAPTER 7: Cytotoxic Chemotherapy inClinical Treatment of Cancer; I. INTRODUCTION; II. DNA-DAMAGING AGENTS; III. ANTIMETABOLITES IV. ANTIMITOTICS V. CHEMOTHERAPY REGIMENS; References; Useful Web Sites; CHAPTER 8: Targeted Therapeutics in Cancer Treatment; I. INTRODUCTION; II. CELL CYCLE; III. THE MAPK FAMILY; IV. CHALLENGES IN THE CLINICAL DEVELOPMENT OF SIGNAL TRANSDUCTION INHIBITORS; References; CHAPTER 9: Concepts in Pharmacology and Toxicology; I. INTRODUCTION; II. CONCEPTS IN PHARMACOKINETICS; III. CONCEPTS IN TOXICOLOGY; IV. CLINICAL CONCERNS FOR PHARMACOLOGY AND SAFETY; V. CONCLUSION; References; Further Reading; CHAPTER 10: Cancer Immunotherapy:Challenges and Opportunities; I. INTRODUCTION II. PREREQUISITES FOR EFFECTIVE CANCER IMMUNOTHERAPY: IDENTIFYING TUMOR ANTIGENS III. ADOPTIVE ("PASSIVE") IMMUNOTHERAPY; IV. ACTIVE-SPECIFIC IMMUNOTHERAPY: VACCINES; V. CANCER-INDUCED IMMUNOSUPPRESSION IMPINGES ON IMMUNOTHERAPY; VI. CANCER IMMUNOTHERAPY IN MICE VERSUS HUMANS; VII. IMMUNOTHERAPY AND CANCER STEM CELLS; VIII. AUTOIMMUNITY RESULTING FROM CANCER IMMUNOTHERAPY; IX. CONCLUSION AND FUTURE CONSIDERATIONS; References; CHAPTER 11: Cancer Vaccines; I. INTRODUCTION; II. TUMOR ANTIGENS; III. SPONTANEOUS IMMUNITY TO CANCER; IV. TOLERAGENIC PRESSURE ON IMMUNITY TO CANCER V. IMMUNE RESPONSES TO CONVENTIONAL VACCINES |
| Record Nr. | UNINA-9910784658103321 |
| Amsterdam ; ; Boston, : Academic Press, c2007 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Cancer immunotherapy : immune suppression and tumor growth / / [edited by] George Prendergast, Elizabeth M. Jaffee
| Cancer immunotherapy : immune suppression and tumor growth / / [edited by] George Prendergast, Elizabeth M. Jaffee |
| Pubbl/distr/stampa | Amsterdam ; ; Boston, : Academic Press, c2007 |
| Descrizione fisica | 1 online resource (429 p.) |
| Disciplina | 616.99/4061 |
| Altri autori (Persone) |
PrendergastGeorge C
JaffeeElizabeth M |
| Soggetto topico |
Cancer - Immunotherapy
Antineoplastic agents - Therapeutic use Tumors - Immunological aspects |
| ISBN |
1281020451
9786611020453 0080521851 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Front cover; Cancer Immunotherapy: Immune Suppression and Tumor Growth; Copyright page; Table of contents; Contributors; PART I: PRINCIPLES OF CANCER IMMUNOBIOLOGY; CHAPTER 1: Introduction; I. OVERVIEW; II. HISTORICAL BACKGROUND; III. LOOKING AHEAD: MARRYING CHEMOTHERAPY AND IMMUNOTHERAPY; IV. PARTS OF THE BOOK; References; Further Reading; CHAPTER 2: Cancer Immunoediting: From Immune Surveillance to Immune Escape; I. INTRODUCTION; II. CANCER IMMUNE SURVEILLANCE; III. CANCER IMMUNOEDITING; IV. CONCLUDING REMARKS; References
CHAPTER 3: Immunosurveillance: Innate and Adaptive Antitumor ImmunityI. INTRODUCTION; II. INNATE ANTITUMOR RESPONSES; III. INNATE IMMUNE CELLS; IV. ADAPTIVE ANTITUMOR RESPONSES; V. THE INTERPLAY OF INNATE AND ADAPTIVE ANTITUMOR IMMUNITY; VI. CONCLUSION; References; CHAPTER 4: Cytokine Regulation of Immune Tolerance to Tumors; I. INTRODUCTION; II. CYTOKINE REGULATION OF IMMUNE TOLERANCE TO TUMORS; III. SUMMARY AND FUTURE PERSPECTIVES; References; CHAPTER 5: Immunological Sculpting:Natural Killer Cell Receptorsand Ligands; I. INTRODUCTION; II. ACTIVATING HUMAN NK RECEPTORS III. INHIBITORY NK RECEPTORSIV. THE LY49 RECEPTOR FAMILY; V. IMMUNOTHERAPY APPROACHES; VI. CONCLUSION; References; Further Reading; CHAPTER 6: Immune Escape:Immunosuppressive Networks; I. INTRODUCTION; II. IMBALANCE BETWEEN MATURE DCs AND IMMATURE DCs; III. IMBALANCE BETWEEN STIMULATORY AND INHIBITORY B7 FAMILY MOLECULES; IV. IMBALANCE BETWEEN REGULATORY T CELLS AND CONVENTIONAL T CELLS; V. CONCLUDING REMARKS; References; PART II: CANCER THERAPEUTICS; CHAPTER 7: Cytotoxic Chemotherapy inClinical Treatment of Cancer; I. INTRODUCTION; II. DNA-DAMAGING AGENTS; III. ANTIMETABOLITES IV. ANTIMITOTICS V. CHEMOTHERAPY REGIMENS; References; Useful Web Sites; CHAPTER 8: Targeted Therapeutics in Cancer Treatment; I. INTRODUCTION; II. CELL CYCLE; III. THE MAPK FAMILY; IV. CHALLENGES IN THE CLINICAL DEVELOPMENT OF SIGNAL TRANSDUCTION INHIBITORS; References; CHAPTER 9: Concepts in Pharmacology and Toxicology; I. INTRODUCTION; II. CONCEPTS IN PHARMACOKINETICS; III. CONCEPTS IN TOXICOLOGY; IV. CLINICAL CONCERNS FOR PHARMACOLOGY AND SAFETY; V. CONCLUSION; References; Further Reading; CHAPTER 10: Cancer Immunotherapy:Challenges and Opportunities; I. INTRODUCTION II. PREREQUISITES FOR EFFECTIVE CANCER IMMUNOTHERAPY: IDENTIFYING TUMOR ANTIGENS III. ADOPTIVE ("PASSIVE") IMMUNOTHERAPY; IV. ACTIVE-SPECIFIC IMMUNOTHERAPY: VACCINES; V. CANCER-INDUCED IMMUNOSUPPRESSION IMPINGES ON IMMUNOTHERAPY; VI. CANCER IMMUNOTHERAPY IN MICE VERSUS HUMANS; VII. IMMUNOTHERAPY AND CANCER STEM CELLS; VIII. AUTOIMMUNITY RESULTING FROM CANCER IMMUNOTHERAPY; IX. CONCLUSION AND FUTURE CONSIDERATIONS; References; CHAPTER 11: Cancer Vaccines; I. INTRODUCTION; II. TUMOR ANTIGENS; III. SPONTANEOUS IMMUNITY TO CANCER; IV. TOLERAGENIC PRESSURE ON IMMUNITY TO CANCER V. IMMUNE RESPONSES TO CONVENTIONAL VACCINES |
| Record Nr. | UNINA-9910809106203321 |
| Amsterdam ; ; Boston, : Academic Press, c2007 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Cancer immunotherapy principles and practice / / Lisa H. Butterfield, editors [and five others]
| Cancer immunotherapy principles and practice / / Lisa H. Butterfield, editors [and five others] |
| Pubbl/distr/stampa | New York, [New York] : , : Demos Medical Publishing, , 2017 |
| Descrizione fisica | 1 online resource (921 pages) : illustrations |
| Disciplina | 616.994061 |
| Soggetto topico |
Cancer - Immunotherapy
Tumors - Immunological aspects |
| Soggetto genere / forma | Electronic books. |
| ISBN | 1-61705-273-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910480445703321 |
| New York, [New York] : , : Demos Medical Publishing, , 2017 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Cancer immunotherapy principles and practice / / Lisa H. Butterfield, editors [and five others]
| Cancer immunotherapy principles and practice / / Lisa H. Butterfield, editors [and five others] |
| Pubbl/distr/stampa | New York, [New York] : , : Demos Medical Publishing, , 2017 |
| Descrizione fisica | 1 online resource (921 pages) : illustrations |
| Disciplina | 616.994061 |
| Soggetto topico |
Cancer - Immunotherapy
Tumors - Immunological aspects |
| Soggetto genere / forma | Electronic books. |
| ISBN | 1-61705-273-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910530734803321 |
| New York, [New York] : , : Demos Medical Publishing, , 2017 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Cancer Treatment: An Interdisciplinary Approach / / edited by Nima Rezaei
| Cancer Treatment: An Interdisciplinary Approach / / edited by Nima Rezaei |
| Edizione | [1st ed. 2023.] |
| Pubbl/distr/stampa | Cham : , : Springer Nature Switzerland : , : Imprint : Springer, , 2023 |
| Descrizione fisica | 1 online resource (XIII, 426 p. 67 illus., 60 illus. in color.) |
| Disciplina | 616.994 |
| Collana | Interdisciplinary Cancer Research |
| Soggetto topico |
Cancer - Treatment
Cancer Tumors - Immunological aspects Stem cells Oncology Neoplasms - therapy Immunotherapy Stem Cells Cancer Therapy Cancer Biology Tumour Immunology Cancer Stem Cells |
| ISBN | 3-031-43983-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Cancer: A Complex Problem Requiring Interdisciplinary Research -- Tumor Immunology and Immunotherapy -- New Approaches Targeting Immuno-oncology and Tumor Microenvironment -- Tumor Infiltrating Lymphocytes as Markers of the Antitumor Therapy Efficacy: Myth or Reality? -- Recent Innovative Approaches to Intensify the Efficacy and Safety of CAR-T Cell Therapy in Cancers -- An Updated Focus on Immune Checkpoint Inhibitors and Tubulointerstitial Nephritis -- Cancer Stem Cell as a Target for Immunotherapeutic Approach -- Immunological Properties of Manipulated Hematopoietic Stem Cell Grafts -- Recent Development of Quinoline Derivatives as Anticancer Agents: 2015-2022 -- Antitumor Immunotherapy: Effect of COVID-19 in Cancer Patients -- The Use of Immunotherapy in Cancer Patients with Autoimmune Diseases -- The Effects of Low-dose Non-ionizing and Ionizing Radiation on Wound Healing and Cancer -- How Is Cancer Under the Sea? Hyperbaric Oxygen Therapy in Cancer -- Interventional Oncology Techniques: A Primer for Non-Users -- Future Perspectives of Phytochemicals in Cancer Therapy -- Integrated Palliative Cancer Care: From an Interdisciplinary Perspective -- Correction to: Cancer: A Complex Problem Requiring Interdisciplinary Research. |
| Record Nr. | UNINA-9910799499503321 |
| Cham : , : Springer Nature Switzerland : , : Imprint : Springer, , 2023 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Cancer vaccines and tumor immunity [[electronic resource] /] / [edited by] Rimas Orentas, James W. Hodge, Bryon D. Johnson
| Cancer vaccines and tumor immunity [[electronic resource] /] / [edited by] Rimas Orentas, James W. Hodge, Bryon D. Johnson |
| Pubbl/distr/stampa | Hoboken, N.J., : Wiley-Interscience, c2008 |
| Descrizione fisica | 1 online resource (352 p.) |
| Disciplina | 616.99/407 |
| Altri autori (Persone) |
OrentasRimas
HodgeJames W JohnsonBryon D |
| Soggetto topico |
Cancer vaccines
Tumors - Immunological aspects |
| ISBN |
1-281-23718-3
9786611237189 0-470-17011-5 0-470-17010-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
CANCER VACCINES AND TUMOR IMMUNITY; CONTENTS; Contributors; Foreword CANCER VACCINES AND CANCER IMMUNOTHERAPY: A NEW PARADIGM; I INTRODUCTION; 1 CANCER VACCINES: PROGRESS AND PROMISE; II ADJUVANT THERAPY: ENHANCING THE ENDOGENOUS IMMUNE RESPONSE; 2 FULLY SYNTHETIC CARBOYHYDRATE-BASED ANTITUMOR VACCINES; 3 BACILLUS CALMETTE-GUÉRIN IMMUNOTHERAPY OF GENITOURINARY CANCER; 4 STIMULATION OF TOLL-LIKE RECEPTOR 9 FOR ENHANCING VACCINATION; III ANTIGEN-SPECIFIC THERAPY: NOVEL PRESENTATION OF PEPTIDE AND PROTEIN ANTIGENS; 5 POLYEPITOPE VACCINES
6 ANTIGEN-SPECIFIC CANCER IMMUNOTHERAPY: HPV-ASSOCIATED CERVICAL CANCER AS A MODEL SYSTEM7 POXVIRAL VECTORS FOR CANCER VACCINES: STATE OF THE ART; 8 IMMUNOTHERAPEUTIC STRATEGIES AGAINST CANCER USING Listeria monocytogenes AS A VECTOR FOR TUMOR ANTIGENS; 9 COUPLING INNATE AND ADAPTIVE IMMUNITY WITH YEAST-BASED CANCER IMMUNOTHERAPY; IV CELL-BASED THERAPY: USING CANCER CELLS AS A MEANS TO INDUCE SPECIFIC TUMOR IMMUNITY; 10 ALLOGENEIC WHOLE-CELL VACCINES; 11 JUMP-STARTING TUMOR IMMUNITY WITH BREAST CANCER THERAPEUTICS; 12 T-REGULATORY CELL MANIPULATION IN TUMOR IMMUNOTHERAPY 13 TUMOR VACCINATION AFTER AUTOLOGOUS HSCT: WHAT HAS BEEN LEARNED FROM EXPERIMENTAL MODELS14 VACCINES IN THE SETTING OF HEMATOPOIETIC STEM CELL TRANSPLANTATION; 15 INTRATUMOR GENERATION OF VIGOROUS ANTITUMOR IMMUNE RESPONSES; 16 CANCER IMMUNOTHERAPY: UNTAPPING THE POTENTIAL OF COSTIMULATORY MOLECULES BEYOND CTLA-4; V DEFINING EFFECTIVE CLINICAL RESPONSES; 17 ADVANCES IN IMMUNE MONITORING STRATEGIES FOR CANCER VACCINES AND IMMUNOTHERAPY; 18 IMMUNE EVALUATION OF CANCER VACCINES; Index |
| Record Nr. | UNINA-9910145587103321 |
| Hoboken, N.J., : Wiley-Interscience, c2008 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Cancer vaccines and tumor immunity [[electronic resource] /] / [edited by] Rimas Orentas, James W. Hodge, Bryon D. Johnson
| Cancer vaccines and tumor immunity [[electronic resource] /] / [edited by] Rimas Orentas, James W. Hodge, Bryon D. Johnson |
| Pubbl/distr/stampa | Hoboken, N.J., : Wiley-Interscience, c2008 |
| Descrizione fisica | 1 online resource (352 p.) |
| Disciplina | 616.99/407 |
| Altri autori (Persone) |
OrentasRimas
HodgeJames W JohnsonBryon D |
| Soggetto topico |
Cancer vaccines
Tumors - Immunological aspects |
| ISBN |
1-281-23718-3
9786611237189 0-470-17011-5 0-470-17010-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
CANCER VACCINES AND TUMOR IMMUNITY; CONTENTS; Contributors; Foreword CANCER VACCINES AND CANCER IMMUNOTHERAPY: A NEW PARADIGM; I INTRODUCTION; 1 CANCER VACCINES: PROGRESS AND PROMISE; II ADJUVANT THERAPY: ENHANCING THE ENDOGENOUS IMMUNE RESPONSE; 2 FULLY SYNTHETIC CARBOYHYDRATE-BASED ANTITUMOR VACCINES; 3 BACILLUS CALMETTE-GUÉRIN IMMUNOTHERAPY OF GENITOURINARY CANCER; 4 STIMULATION OF TOLL-LIKE RECEPTOR 9 FOR ENHANCING VACCINATION; III ANTIGEN-SPECIFIC THERAPY: NOVEL PRESENTATION OF PEPTIDE AND PROTEIN ANTIGENS; 5 POLYEPITOPE VACCINES
6 ANTIGEN-SPECIFIC CANCER IMMUNOTHERAPY: HPV-ASSOCIATED CERVICAL CANCER AS A MODEL SYSTEM7 POXVIRAL VECTORS FOR CANCER VACCINES: STATE OF THE ART; 8 IMMUNOTHERAPEUTIC STRATEGIES AGAINST CANCER USING Listeria monocytogenes AS A VECTOR FOR TUMOR ANTIGENS; 9 COUPLING INNATE AND ADAPTIVE IMMUNITY WITH YEAST-BASED CANCER IMMUNOTHERAPY; IV CELL-BASED THERAPY: USING CANCER CELLS AS A MEANS TO INDUCE SPECIFIC TUMOR IMMUNITY; 10 ALLOGENEIC WHOLE-CELL VACCINES; 11 JUMP-STARTING TUMOR IMMUNITY WITH BREAST CANCER THERAPEUTICS; 12 T-REGULATORY CELL MANIPULATION IN TUMOR IMMUNOTHERAPY 13 TUMOR VACCINATION AFTER AUTOLOGOUS HSCT: WHAT HAS BEEN LEARNED FROM EXPERIMENTAL MODELS14 VACCINES IN THE SETTING OF HEMATOPOIETIC STEM CELL TRANSPLANTATION; 15 INTRATUMOR GENERATION OF VIGOROUS ANTITUMOR IMMUNE RESPONSES; 16 CANCER IMMUNOTHERAPY: UNTAPPING THE POTENTIAL OF COSTIMULATORY MOLECULES BEYOND CTLA-4; V DEFINING EFFECTIVE CLINICAL RESPONSES; 17 ADVANCES IN IMMUNE MONITORING STRATEGIES FOR CANCER VACCINES AND IMMUNOTHERAPY; 18 IMMUNE EVALUATION OF CANCER VACCINES; Index |
| Record Nr. | UNINA-9910824723903321 |
| Hoboken, N.J., : Wiley-Interscience, c2008 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Cytokine and Chemokine Networks in Cancer [[electronic resource] /] / edited by Manzoor Ahmad Mir
| Cytokine and Chemokine Networks in Cancer [[electronic resource] /] / edited by Manzoor Ahmad Mir |
| Edizione | [1st ed. 2023.] |
| Pubbl/distr/stampa | Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2023 |
| Descrizione fisica | 1 online resource (449 pages) |
| Disciplina | 616.994061 |
| Soggetto topico |
Cancer
Tumors - Immunological aspects Therapeutics Neoplasms Chemokines Cytokines Cancers Tumour Immunology |
| ISBN |
9789819946570
9789819946563 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Chapter 1_Introduction to Cancer -- Chapter 2_Expression pattern of Chemokines in Cancer -- Chapter 3_Implications of Cytokine-Chemokine Heterogenity in Cancer -- Chapter 4_Cytokine and chemokines networks in cancer stemness -- Chapter 5_Cytokine and chemokines networks in angiogeneis -- Chapter 6_Role of Cytokine-Chemokine cascades in Epithelial to Mesenchymal Transition -- Chapter 7_Role of Chemokines in establishment of Metastatic Niche -- Chapter 8_CXCL12-CXCR4 axis in Metastasis -- Chapter 9_Chemokine and cytokine networks in the tumor microenvironment -- Chapter 10_CXCL9, CXCL10, CXCL11/CXCR3 axis and Immune Activation -- Chapter 11_CXCL8-CXCR1/2 axis in cancer and inflammatory diseases -- Chapter 12_Cytokine and Chemokine Networks in Therapeutic Resistance -- Chapter 13_Prognostic and diagnostic significance of Chemokines and cytokines in cancer -- Chapter 14_Therapeutic implications of Chemokines and cytokines networks in cancer -- Chapter 15_Chemokines in cancer therapy. |
| Record Nr. | UNINA-9910754099103321 |
| Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2023 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Endoplasmic reticulcum and its role in tumor immunity [[electronic resource] /] / edited by: Paul Eggleton, Marek Michalak and Edwin Bremer
| Endoplasmic reticulcum and its role in tumor immunity [[electronic resource] /] / edited by: Paul Eggleton, Marek Michalak and Edwin Bremer |
| Pubbl/distr/stampa | Frontiers Media SA, 2016 |
| Descrizione fisica | 1 online resource (101 pages) : illustrations; digital, PDF file(s) |
| Disciplina | 571.6/5 |
| Collana |
Frontiers Research Topics
Frontiers in Oncology |
| Soggetto topico |
Endoplasmic reticulum
Tumors - Immunological aspects Immunology Oncology Endoplasmic Reticulum Stress |
| Soggetto non controllato |
Autoimmunity
Angiogenesis T-cell receptors genome damage phage display Aminopeptidases Grp170 Oxidoreductases Vaccines chaperones |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910136799903321 |
| Frontiers Media SA, 2016 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
